WASHINGTON: The pharmaceutical industry and healthcare communicators advocated for guidelines that would define the way they use the Web to communicate during the Food and Drug Administration (FDA)'s two-day social media hearings.
The federal agency scheduled the hearings, held November 12 and 13 in Washington, to gather information from drug makers, PR and advertising agencies, Internet companies, and consumer advocates about how the Web and social networking sites are being used to promote and communicate FDA-regulated products.
The FDA currently uses the ...